UPDATE: On January 12, 2026, the federal government announced it would drop its appeal of Judge Walker’s order blocking implementation of the Pilot Program and return it back to HRSA for ...

Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the ...

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...

A federal judge has issued a preliminary injunction halting the Department of Health and Human Services’ (HHS) 340B Rebate Model Pilot Program, which was scheduled to take effect on January 1, 2026.

Novo Nordisk today announced sales and operating profit growth at constant exchange rates (CER) for 2025 and released the 2026 full-year sales and operating profit outlook at CER. 2025 sales and ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate Model Pilot Program.

After federal judges blocked HHS’ 340B rebate pilot program from taking effect Jan. 1, HHS is discussing whether to reconsider the drug manufacturers’ plans, according to court documents. On Jan. 7, ...

The gaming doesn’t stop there. Some large hospital systems have figured out how to rebrand urban hospitals as “rural” facilities to qualify for government cash reimbursements intended for rural ...

Amgen (NASDAQ: AMGN) today announced financial results for the fourth quarter and full year of 2025 versus the ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal wall, with a federal appeals court keeping a freeze on a controversial pilot ...